Skip to main content
Log in

Contributions of Drug Solubilization, Partitioning, Barrier Disruption, and Solvent Permeation to the Enhancement of Skin Permeation of Various Compounds with Fatty Acids and Amines

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

The contributions of several proposed mechanisms by which fatty acids and amines might increase skin permeation rates were assessed. Permeation rates of model diffusants with diverse physicochemical properties (naloxone, testosterone, benzoic acid, indomethacin, fluorouracil, and methotrexate) through human skin were measured in vitro. The enhancers evaluated were capric acid, lauric acid, neodecanoic acid, and dodecylamine. Increased drug solubility in the vehicle, propylene glycol (PG), in some cases accounted for the increases in flux in the presence of adjuvants, since permeability coefficients were unchanged. Partition coefficients of some drugs into isopropyl myristate or toluene were increased by the adjuvants, but this did not occur for combinations of an acid with a base (adjuvant-drug or drug-adjuvant). Increases in flux not accounted for by increases in drug solubility or partitioning were assumed to involve disruption of the barrier function of skin (increased skin diffusivity). All fatty acids increased skin diffusivity of naloxone, testosterone, indomethacin, and fluorouracil but not of methotrexate or benzoic acid. Dodecylamine increased skin diffusivity only for fluorouracil. Capric acid and dodecylamine, but not lauric acid or neodecanoic acid, increased the skin permeation rate of PG, suggesting that enhanced solvent penetration could also be involved as a mechanism for increased skin permeation of the drug. However, the increase in PG flux due to dodecylamine was nullified when methotrexate was added to the vehicle, possibly because of a dodecylamine/methotrexate interaction. These studies demonstrate that drug solubilization in the vehicle, increased partitioning, increased solvent penetration, and barrier disruption each can contribute to increased skin permeation rates in the presence of fatty acids and amines. The relative contributions of the mechanisms vary with the drug, the adjuvant, and the vehicle.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. E. R. Cooper. J. Pharm. Sci. 73:1153–1156 (1984).

    Google Scholar 

  2. E. R. Cooper, E. W. Merritt, and R. L. Smith. J. Pharm. Sci. 74:688–689 (1985).

    Google Scholar 

  3. B. J. Aungst, N. J. Rogers, and E. Shefter. Int. J. Pharm. 33:225–234 (1986).

    Google Scholar 

  4. B. W. Barry. J. Contr. Res. 6:85–97 (1987).

    Google Scholar 

  5. G. M. Golden, J. E. McKie, and R. O. Potts. J. Pharm. Sci. 76:25–28 (1987).

    Google Scholar 

  6. P. G. Green and J. Hadgraft. Int. J. Pharm. 37:251–255 (1987).

    Google Scholar 

  7. P. G. Green, R. H. Guy, and J. Hadgraft. Int. J. Pharm. 48:103–111 (1988).

    Google Scholar 

  8. M. Yamada, Y. Uda, and Y. Tanigawara. Chem. Pharm. Bull. 35:3399–3406 (1987).

    Google Scholar 

  9. P. V. Raykar, M.-C. Fung, and B. D. Anderson. Pharm. Res. 5:140–150 (1988).

    Google Scholar 

  10. B. J. Aungst. Pharm. Res. 6:244–247 (1989).

    Google Scholar 

  11. S. J. Lee and S. W. Kim. J. Contr. Rel. 6:3–13 (1987).

    Google Scholar 

  12. P. Langguth and E. Mutschler. Arzneim. Forsch. 37:1362–1366 (1987).

    Google Scholar 

  13. T. Ishikura, T. Nagai, Y. Sakai, T. Shishikura, H. Ebisawa, and Y. Machida. Drug Design Deliv. 1:285–295 (1987).

    Google Scholar 

  14. C.-S. Young, C.-K. Shim, M.-H. Lee, and S.-K. Kim. Int. J. Pharm. 45:59–64 (1988).

    Google Scholar 

  15. B. Mollgaard and A. Hoelgaard. Acta Pharm. Suec. 20:443–450 (1983).

    Google Scholar 

  16. F. Kaiho, H. Nomura, E. Makabe, and Y. Kato. Chem. Pharm. Bull. 35:2928–2934 (1987).

    Google Scholar 

  17. M. Mahjour, B. E. Mauser, and M. B. Fawzi. Int. J. Pharm. 56:1–11 (1989).

    Google Scholar 

  18. K. Sato, K. Sugibayashi, and Y. Morimoto. Int. J. Pharm. 43:31–40 (1988).

    Google Scholar 

  19. R. Kadir, D. Stempler, Z. Liron, and S. Cohen. J. Pharm. Sci. 76:774–779 (1987).

    Google Scholar 

  20. R. Kadir, D. Stempler, Z. Liron, and S. Cohen. J. Pharm. Sci. 77:409–413 (1988).

    Google Scholar 

  21. C. Hansch and A. Leo. Subtituent Constants for Correlation Analysis in Chemistry and Biology, John Wiley & Sons, New York, 1979.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aungst, B.J., Blake, J.A. & Hussain, M.A. Contributions of Drug Solubilization, Partitioning, Barrier Disruption, and Solvent Permeation to the Enhancement of Skin Permeation of Various Compounds with Fatty Acids and Amines. Pharm Res 7, 712–718 (1990). https://doi.org/10.1023/A:1015859320604

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015859320604

Navigation